Balyasny Asset Management’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$3.16M Buy
2024
Q1
Sell
2023
Q4
$412K Buy
2023
Q3
Sell
2023
Q2
$4.85M Buy
2023
Q1
Sell
2022
Q4
$6.67M Buy
2022
Q3
$857K Buy
2022
Q2
Sell
2022
Q1
$81K Buy
2021
Q1
Sell
2020
Q4
$2.77M Buy